Detalhe da pesquisa
1.
SARS-CoV-2 Variants and Vaccines.
N Engl J Med
; 385(2): 179-186, 2021 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34161052
2.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med
; 384(6): 497-511, 2021 02 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33264556
3.
Advances and gaps in SARS-CoV-2 infection models.
PLoS Pathog
; 18(1): e1010161, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35025969
4.
An introduction to the Marburg virus vaccine consortium, MARVAC.
PLoS Pathog
; 18(10): e1010805, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36227853
5.
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
Clin Trials
; 19(6): 647-654, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35866633
6.
COVID-19 vaccine trials: The potential for "hybrid" analyses.
Clin Trials
; 18(4): 391-397, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34041932
7.
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
Clin Trials
; 18(3): 335-342, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33535811
8.
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report.
Clin Infect Dis
; 71(11): 2872-2879, 2020 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31784751
9.
Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.
Clin Infect Dis
; 69(6): 1071-1078, 2019 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30689799
10.
Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic.
Am J Epidemiol
; 188(7): 1319-1327, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30941398
11.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Lancet
; 389(10068): 505-518, 2017 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28017403
12.
A randomized, controlled trial of an aerosolized vaccine against measles.
N Engl J Med
; 372(16): 1519-29, 2015 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-25875257
13.
Considerations in boosting COVID-19 vaccine immune responses.
Lancet
; 398(10308): 1377-1380, 2021 10 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34534516
14.
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
Lancet
; 396(10263): 1611-1613, 2020 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33125926
15.
COVID-19 vaccine trials should seek worthwhile efficacy.
Lancet
; 396(10253): 741-743, 2020 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32861315
16.
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Lancet
; 386(9996): 857-66, 2015 Aug 29.
Artigo
Inglês
| MEDLINE | ID: mdl-26248676
17.
Data sharing for novel coronavirus (COVID-19).
Bull World Health Organ
; 98(3): 150, 2020 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32132744
18.
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply.
Lancet
; 391(10125): 1021-1022, 2018 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-29565012
19.
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in Guinea.
Virus Evol
; 9(1): vead007, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36926449
20.
Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
Lancet
; 387(10027): 1509-1510, 2016 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27115974